INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 May 2013
Total net assets |
£163.8m |
NAV per share |
297.0p |
Share price |
258.5p |
Total value of unquoted investments |
£25.8m |
Total number of portfolio companies |
70 |
Cash |
1% NAV |
Cash committed and reserved to unquoted investments |
(4.5%) NAV |
Top Ten Holdings
Company Name |
% NAV |
Gilead Amgen Celgene |
6.9 6.6 6.1 |
Alexion |
5.0 |
Onyx |
4.2 |
Biogen |
3.9 |
Aptiv |
3.6 |
Insulet |
2.8 |
Regeneron |
2.7 |
Achillion |
2.4 |
|
----------- |
Total |
44.2 |
Geographical Allocation |
% |
United States & Canada |
90 |
Europe |
9 |
Cash |
1 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
83 |
Unquoted |
16 |
Cash |
1 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
25 JUNE 2013